scholarly article | Q13442814 |
P50 | author | Shahina Pardhan | Q54828941 |
Michael Harrison | Q60457757 | ||
Arit Udoh | Q89829381 | ||
P2093 | author name string | Ali Hassan | |
Anant Sharma | |||
Garry Barton | |||
Sajjad Ahmad | |||
Yannis Pappas | |||
Rupert Richard Alexander Bourne | |||
Shafi Balal | |||
Erica Cook | |||
Karen Hayden | |||
Benjamin Sharma | |||
Mohammad Wasil | |||
P2860 | cites work | Autologous serum eye drops for dry eye | Q24200233 |
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials | Q24614759 | ||
Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report | Q26825405 | ||
The effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: a scanning electron microscope study | Q28342217 | ||
Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies | Q28360278 | ||
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). | Q34177200 | ||
Autologous blood injection for late-onset filtering bleb leak | Q34299528 | ||
Treatment of dry eye by autologous serum application in Sjögren's syndrome | Q35309629 | ||
Prevention of indocyanine green toxicity on retinal pigment epithelium with whole blood in stain-assisted macular hole surgery | Q36215024 | ||
Treatment of chronic dry eye: focus on cyclosporine | Q37236096 | ||
Fingerprick autologous blood: a novel treatment for dry eye syndrome | Q39378640 | ||
Carbomer- versus cellulose-based artificial-tear formulations: morphologic and toxicologic effects on a corneal cell line. | Q41022664 | ||
Use of autologous whole blood during internal limiting membrane peeling and macular hole surgery is protective for indocyanine green toxicity | Q43139146 | ||
Blood-assisted internal limiting membrane peeling for macular hole repair. | Q45980430 | ||
Heparinized autologous blood for visualization of the internal limiting membrane during macular hole surgery | Q46732873 | ||
The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency | Q47338176 | ||
Allergic conjunctivitis and dry eye syndrome. | Q51356735 | ||
Design and analysis of pilot studies: recommendations for good practice. | Q51996366 | ||
Utility assessment among patients with dry eye disease. | Q53379868 | ||
Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca | Q71320063 | ||
Combination of autologous blood injection and bleb compression sutures to treat hypotony maculopathy | Q73287943 | ||
Prevalence of and risk factors for dry eye syndrome | Q74298539 | ||
Rheology of tear film lipid layer spread in normal and aqueous tear-deficient dry eyes | Q81247467 | ||
Long-term success with autologous blood injection for leaking trabeculectomy blebs | Q83160939 | ||
Compression sutures with autologous blood injection for leaking trabeculectomy blebs | Q83557696 | ||
Sutureless and glue-free conjunctival autograft in pterygium surgery: a case series | Q84353336 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | eye disease | Q3041498 |
P304 | page(s) | e026770 | |
P577 | publication date | 2018-10-31 | |
P1433 | published in | BMJ Open | Q17003470 |
P1476 | title | The feasibility of finger prick autologous blood (FAB) as a novel treatment for severe dry eye disease (DED): protocol for a randomised controlled trial | |
P478 | volume | 8 |
Search more.